// App-Quantinova.ai

: Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data

Researchers

Presenter

  • Afisi Ismaila

Principal Investigators

  • Rafal Jakubanis

  • Tim Holbrook

  • Yogesh Punekar

  • Robert Wood

  • Wilhelmine Meeraus

Medical Centers

  • NIH/NIEHS, Research Triangle Park, United States of America

  • Adelphi Real World, Bollington, United Kingdom

  • ViiV Healthcare, Brentwood, United Kingdom

  • GSK, Uxbridge, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved